Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: life extension – Page 252

I think this might be the answer to the question we’ve all been debating here lately. Provided it ACTUALLY happens, and that it includes others (like Jeff Bezos), and that it happens within a transparent, focused, well structured and effective framework.

It’s not the end all be all to wealth inequity, but it IS a good start and could really help us avoid another tribal political dust up and focus on a worthy, positive, and equitable posthuman (or whatever it is that make… See more.

The billionaire Elon Musk said he’d sell Tesla stock and donate the proceeds if the UN could prove that just a tiny percentage of his wealth could save tens of millions of lives.

Musk was responding to comments by David Beasley, the director of the UN’s World Food Programme, who told CNN’s “Connect the World” last week that a $6 billion donation from billionaires such as Musk and Jeff Bezos could help 42 million people who he said were “literally going to die if we don’t reach them.”

Musk is the world’s richest man and recently became the first person in the Bloomberg Billionaires Index ever to have an estimated net worth north of $300 billion.

Read more | >

A few days ago, United Nations World Food Program (WFP) director David Beasley told CNN that a small group of ultra-wealthy individuals such as Tesla and SpaceX CEO Elon Musk could help solve world hunger with just a fraction of their net worth. Musk’s net worth currently stands at $311 billion thanks to a recent rally in TSLA stock, effectively making the CEO the world’s wealthiest individual today.

While speaking at CNN’s Connect the World with Becky Anderson, Beasley called for billionaires to “step up now, on a one-time basis.” He also noted that even just 2% of Musk’s current net worth could solve world hunger. This translates to roughly about $6 billion. “$6 billion to help 42 million people that are literally going to die if we don’t reach them. It’s not complicated,” the UN WFP director said.

Musk has now responded to Beasley’s statements. While responding to a post on Twitter which highlighted that the UN World Food Program actually raised $8.4 billion in 2,020 Musk noted that if the WFP could explain exactly how $6 billion would solve world hunger, then he would be more than willing to sell some TSLA stock right now. This is a key point as most of Musk’s net worth is tied to his majority stake in Tesla. This means that for Musk to have $6 billion in cash, he’d have to sell TSLA stock, which would then be taxed.

Read more | >

A commonly available oral diuretic pill approved by the U.S. Food and Drug Administration may be a potential candidate for an Alzheimer’s disease treatment for those who are at genetic risk, according to findings published in Nature Aging. The research included analysis showing that those who took bumetanide — a commonly used and potent diuretic — had a significantly lower prevalence of Alzheimer’s disease compared to those not taking the drug. The study, funded by the National Institute on Aging (NIA), part of the National Institutes of Health, advances a precision medicine approach for individuals at greater risk of the disease because of their genetic makeup.

The research team analyzed information in databases of brain tissue samples and FDA-approved drugs, performed mouse and human cell experiments, and explored human population studies to identify bumetanide as a leading drug candidate that may potentially be repurposed to treat Alzheimer’s.

“Though further tests and clinical trials are needed, this research underscores the value of big data-driven tactics combined with more traditional scientific approaches to identify existing FDA-approved drugs as candidates for drug repurposing to treat Alzheimer’s disease,” said NIA Director Richard J. Hodes, M.D.

Read more | >

So would the private station be a viable replacement for the ISS? The ageing station, which is a partnership between the US, Russia and other nations, is only funded until 2,024 with a 2028 extension looking probable, but it cannot last forever.

Blue Origin says its space station will be fully operational in the late 2020s, but deadline slippage is common when it comes to huge space-related projects like this one. “They can dream of being fully operational in the late 2020s, but in the space sector they often aim for aspirational targets and if they miss it by a year or two or three then they at least have something they’re aiming for until then,” says space analyst Laura Forczyk. “It’s almost inevitable that things take longer and are more expensive than planned.”

Full Story:

Blue Origin, the space-flight firm owned by Amazon founder Jeff Bezos, is planning to build a space station – with the hopes that it could replace the International Space Station (ISS), which is reaching the end of its life.

The Orbital Reef space station, which Blue Origin is developing in partnership with other space firms including Sierra Space and Boeing, is intended to be a multipurpose destination in orbit, where different companies and governments could pay to send their own astronauts and experiments, and space tourists could visit, says the firm. The station is proposed to be slightly smaller than the ISS, with capacity to house 10 astronauts – the ISS generally carries seven crew members, but it has had as many as 13 at a time.

“We will expand access, lower the cost, and provide all the services and amenities needed to normalize space flight,” said Blue Origin’s Brent Sherwood in a statement. “A vibrant business ecosystem will grow in low Earth orbit, generating new discoveries, new products, new entertainments, and global awareness.”

Continue reading “Can Blue Origin help replace the International Space Station?” | >

Researchers at MIT and Harvard University have designed a way to selectively turn on gene therapies in target cells, including human cells. Their technology can detect specific messenger RNA sequences in cells, and that detection then triggers production of a specific protein from a transgene, or artificial gene.

Because transgenes can have negative and even dangerous effects when expressed in the wrong , the researchers wanted to find a way to reduce off-target effects from gene therapies. One way of distinguishing different types of cells is by reading the RNA sequences inside them, which differ from tissue to tissue.

By finding a way to produce transgene only after “reading” specific RNA sequences inside cells, the researchers developed a technology that could fine-tune in applications ranging from regenerative medicine to cancer treatment. For example, researchers could potentially create new therapies to destroy tumors by designing their system to identify cancer cells and produce a toxic protein just inside those cells, killing them in the process.

Read more | >

A team of researchers publishing in Aging have shown that resveratrol reduces inflammation and partially restores function in a rat model of spinal injury.

In line with previous research

This is far from the first study that aimed to use approaches associated with aging research in order to spur regeneration. For example, we have previously reported that removing senescent cells aids in spinal cord regeneration in a rodent model, at least partially because of the associated reduction in inflammation.

Read more | >